{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T05:18:25Z","timestamp":1790054305385,"version":"4.0.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R24 AA019661"],"award-info":[{"award-number":["R24 AA019661"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1 TR001082"],"award-info":[{"award-number":["UL1 TR001082"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jccjournal.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Critical Care"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.jcrc.2015.12.010","type":"journal-article","created":{"date-parts":[[2015,12,22]],"date-time":"2015-12-22T07:19:46Z","timestamp":1450768786000},"page":"120-125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Azithromycin use and outcomes in severe sepsis patients with and without pneumonia"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6368-4652","authenticated-orcid":false,"given":"Majid","family":"Afshar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clayton L.","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer E.","family":"Layden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9945-0284","authenticated-orcid":false,"given":"Ellen L.","family":"Burnham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcrc.2015.12.010_bb0005","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1183\/09031936.00054108","article-title":"Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia","volume":"33","author":"Restrepo","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcrc.2015.12.010_bb0010","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1007\/s00134-009-1730-y","article-title":"Combination antibiotic therapy with macrolides improves survival in intubated patients with community-acquired pneumonia","volume":"36","author":"Martin-Loeches","year":"2010","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jcrc.2015.12.010_bb0015","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1378\/chest.11-1908","article-title":"Macrolide antibiotics and survival in patients with acute lung injury","volume":"141","author":"Walkey","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.jcrc.2015.12.010_bb0020","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1136\/thoraxjnl-2012-202698","article-title":"Azithromycin for prevention of exacerbations in severe asthma (AZISAST): a multicentre randomised double-blind placebo-controlled trial","volume":"68","author":"Brusselle","year":"2013","journal-title":"Thorax"},{"key":"10.1016\/j.jcrc.2015.12.010_bb0025","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejphar.2005.05.023","article-title":"Modulation of neutrophil and inflammation markers in chronic obstructive pulmonary disease by short-term azithromycin treatment","volume":"517","author":"Parnham","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jcrc.2015.12.010_bb0030","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMoa1104623","article-title":"Azithromycin for prevention of exacerbations of COPD","volume":"365","author":"Albert","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcrc.2015.12.010_bb0035","first-page":"1","article-title":"Macrolide antibiotics for cystic fibrosis","volume":"11","author":"Southern","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jcrc.2015.12.010_bb0040","article-title":"New life for macrolides","author":"Solidoro","year":"2013","journal-title":"Minerva Med"},{"key":"10.1016\/j.jcrc.2015.12.010_bb0045","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1111\/all.12199","article-title":"Macrolides for the long-term management of asthma\u2014a meta-analysis of randomized clinical trials","volume":"68","author":"Reiter","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.jcrc.2015.12.010_bb0050","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/01.qco.0000160901.71813.fe","article-title":"Immunomodulatory effects of antimicrobials in the therapy of respiratory tract infections","volume":"18","author":"Parnham","year":"2005","journal-title":"Curr Opin Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.jcrc.2015.12.010_bb0055","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/j.ijantimicag.2008.06.004","article-title":"Immunomodulatory therapies for sepsis: unexpected effects with macrolides","volume":"32","author":"Giamarellos-Bourboulis","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jcrc.2015.12.010_bb0060","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.diagmicrobio.2015.07.003","article-title":"Analysis of septic biomarker patterns: prognostic value in predicting septic state","volume":"83","author":"Carlyn","year":"2015","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jcrc.2015.12.010_bb0065","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/CCM.0b013e3182a66b9b","article-title":"Macrolides and mortality in critically ill patients with community-acquired pneumonia: a systematic review and meta-analysis","volume":"42","author":"Sligl","year":"2014","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jcrc.2015.12.010_bb0070","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1093\/jac\/dkt475","article-title":"Effect of clarithromycin in patients with suspected gram-negative sepsis: results of a randomized controlled trial","volume":"69","author":"Giamarellos-Bourboulis","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jcrc.2015.12.010_bb0075","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11908-007-0016-1","article-title":"Macrolide immunomodulation of chronic respiratory diseases","volume":"9","author":"Healy","year":"2007","journal-title":"Curr Infect Dis Rep"},{"key":"10.1016\/j.jcrc.2015.12.010_bb0080","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/cid\/cis414","article-title":"Macrolide-based regimens and mortality in hospitalized patients with community-acquired pneumonia: a systematic review and meta-analysis","volume":"55","author":"Asadi","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jcrc.2015.12.010_bb0085","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1056\/NEJMoa022139","article-title":"The epidemiology of sepsis in the United States from 1979 through 2000","volume":"348","author":"Martin","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcrc.2015.12.010_bb0090","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1089\/sur.2013.089","article-title":"Validity of International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) screening for sepsis in surgical mortalities","volume":"15","author":"Ramanathan","year":"2014","journal-title":"Surg Infect (Larchmt)"},{"key":"10.1016\/j.jcrc.2015.12.010_bb0095","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/CCM.0b013e31827e83af","article-title":"Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012","volume":"41","author":"Dellinger","year":"2013","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jcrc.2015.12.010_bb0100","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1128\/MMBR.32.4_Pt_2.493-528.1968","article-title":"Antibiotic inhibitors of the bacterial ribosome","volume":"32","author":"Weisblum","year":"1968","journal-title":"Bacteriol Rev"},{"key":"10.1016\/j.jcrc.2015.12.010_bb0105","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1097\/00003246-200208000-00016","article-title":"Statistical evaluation of ventilator-free days as an efficacy measure in clinical trials of treatments for acute respiratory distress syndrome","volume":"30","author":"Schoenfeld","year":"2002","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jcrc.2015.12.010_bb0110","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1378\/chest.127.2.598","article-title":"Shock on admission day is the best predictor of prolonged mechanical ventilation in the ICU","volume":"127","author":"Estenssoro","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.jcrc.2015.12.010_bb0115","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1136\/thoraxjnl-2012-202296","article-title":"Single versus combination antibiotic therapy in adults hospitalised with community acquired pneumonia","volume":"68","author":"Rodrigo","year":"2013","journal-title":"Thorax"},{"key":"10.1016\/j.jcrc.2015.12.010_bb0120","doi-asserted-by":"crossref","first-page":"S209","DOI":"10.1097\/01.CCM.0000126124.41743.86","article-title":"Endpoints in sepsis trials: more than just 28-day mortality?","volume":"32","author":"Vincent","year":"2004","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jcrc.2015.12.010_bb0125","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1001\/jama.2014.2637","article-title":"Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012","volume":"311","author":"Kaukonen","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jcrc.2015.12.010_bb0130","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1128\/AAC.05798-11","article-title":"Effect of clarithromycin in inflammatory markers of patients with ventilator-associated pneumonia and sepsis caused by Gram-negative bacteria: results from a randomized clinical study","volume":"56","author":"Spyridaki","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jcrc.2015.12.010_bb0135","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0140-6736(12)60953-2","article-title":"Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial","volume":"380","author":"Wong","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jcrc.2015.12.010_bb0140","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/TP.0b013e31824db9da","article-title":"Anti-inflammatory and immunomodulatory properties of azithromycin involved in treatment and prevention of chronic lung allograft rejection","volume":"94","author":"Vos","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.jcrc.2015.12.010_bb0145","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/jac\/dkh519","article-title":"Anti-inflammatory effects of macrolides\u2014an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?","volume":"55","author":"Amsden","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jcrc.2015.12.010_bb0150","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1378\/chest.07-3056","article-title":"Effects of telithromycin in in vitro and in vivo models of lipopolysaccharide-induced airway inflammation","volume":"134","author":"Leiva","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.jcrc.2015.12.010_bb0155","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.4049\/jimmunol.163.5.2909","article-title":"Macrolide antibiotics protect against immune complex\u2013induced lung injury in rats: role of nitric oxide from alveolar macrophages","volume":"163","author":"Tamaoki","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.jcrc.2015.12.010_bb0160","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1164\/ajrccm.157.3.9703098","article-title":"Therapeutic effect of erythromycin on influenza virus\u2013induced lung injury in mice","volume":"157","author":"Sato","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcrc.2015.12.010_bb0165","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1136\/thx.53.3.186","article-title":"Preventive effect of erythromycin on experimental bleomycin-induced acute lung injury in rats","volume":"53","author":"Azuma","year":"1998","journal-title":"Thorax"},{"key":"10.1016\/j.jcrc.2015.12.010_bb0170","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1164\/ajrccm.151.5.7735618","article-title":"Effect of erythromycin on endotoxin-induced microvascular leakage in the rat trachea and lungs","volume":"151","author":"Tamaoki","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcrc.2015.12.010_bb0175","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJMoa1500896","article-title":"Trial of early, goal-directed resuscitation for septic shock","volume":"372","author":"Mouncey","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcrc.2015.12.010_bb0180","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1056\/NEJMoa1404380","article-title":"Goal-directed resuscitation for patients with early septic shock","volume":"371","author":"Investigators","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcrc.2015.12.010_bb0185","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1056\/NEJMoa1401602","article-title":"A randomized trial of protocol-based care for early septic shock","volume":"370","author":"Pro","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcrc.2015.12.010_bb0190","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/cc2917","article-title":"Severe sepsis epidemiology: sampling, selection, and society","volume":"8","author":"Linde-Zwirble","year":"2004","journal-title":"Crit Care"},{"issue":"Suppl. 2","key":"10.1016\/j.jcrc.2015.12.010_bb0195","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/511159","article-title":"Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults","volume":"44","author":"Mandell","year":"2007","journal-title":"Clin Infect Dis"}],"container-title":["Journal of Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883944115006140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883944115006140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T07:28:24Z","timestamp":1692170904000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0883944115006140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":39,"alternative-id":["S0883944115006140"],"URL":"https:\/\/doi.org\/10.1016\/j.jcrc.2015.12.010","relation":{},"ISSN":["0883-9441"],"issn-type":[{"value":"0883-9441","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Azithromycin use and outcomes in severe sepsis patients with and without pneumonia","name":"articletitle","label":"Article Title"},{"value":"Journal of Critical Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcrc.2015.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}